RecruitingPhase 3NCT06810375

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Checked against the public recordLast updated Apr 9, 2026 · Source: ClinicalTrials.gov

StatusRecruiting
PhasePhase 3
U.S. locations1
SponsorGeorge Washington University
01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 3
Sponsor
George Washington University
Interventions being studied
Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®); Drug: Intercostal nerve block
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

Inclusion Criteria: * Video assisted pulmonary resection, pleurodesis or decortication Exclusion Criteria: * Allergy to local anesthetics * Patient undergoing bilateral surgery * Surgery is emergent as deemed by the principal investigator

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • The George Washington University HospitalWashington D.C., District of Columbia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 9, 2026. Always confirm current availability with the study team.

View original record ↗